Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Empliciti on track for European approval in multiple myeloma

Empliciti on track for European approval in multiple myeloma The Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Empliciti (elotuzumab) for use in combination with Celgene's Revlimid (lenalidomide) and corticosteroid drug dexamethasone as a ... The immuno-oncology drug was first

BMS' Empliciti approved by FDA for multiple myeloma

BMS' Empliciti approved by FDA for multiple myeloma time before their disease worsened (19.4 months) compared to participants taking only Revlimid and dexamethasone (14.9 months). ... All told, 78.5% of those taking the Empliciti regimen experienced a complete or partial shrinkage of their tumours

FDA clears Takeda's oral multiple myeloma drug

FDA clears Takeda's oral multiple myeloma drug Ninlaro ( ixazomib; formerly MLN9708) has been cleared for use in combination with Celgene's immunomodulatory drug Revlimid (lenalidomide) and dexamethasone in patients with the blood cancer who have been treated with

Amgen’s Kyprolis approved in Europe

Amgen’s Kyprolis approved in Europe Multiple myeloma drugwins licence three years after gaining US approval. Amgen's Kyprolis has been approved in Europe in combination with Celgene's Revlimid and dexamethasone for the treatment of adults

J&J gets FDA green light for myeloma drug Darzalex

J&J gets FDA green light for myeloma drug Darzalex like Celgene's Revlimid (lenalidomide). ... well as the POLLUX trial which pairs the antibody with Cegene's Revlimid. .

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics